Our findings highlight the potential role of genetic polymorphisms in NGF, BDNF, TH, and EPO in modulating the pathophysiology of ROP through their influence on hematological, neurovascular, and inflammatory pathways. This evidence concerns the gene EPO and retinopathy of prematurity.